| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sudheera Magage, Ales Linhart, Jan Bultas, Jan Vojacek, Martin Mates, Tomas Palecek, Jana Popelová, Jaroslav Tintera, Michael Aschermann, Martin E Goldman, Robert J Desnic. Fabry disease: percutaneous transluminal septal myocardial ablation markedly improved symptomatic left ventricular hypertrophy and outflow tract obstruction in a classically affected male. Echocardiography (Mount Kisco, N.Y.). vol 22. issue 4. 2005-09-01. PMID:15839990. |
fabry disease (alpha-galactosidase a deficiency) is an x-linked recessive lysosomal storage disease in which left ventricular hypertrophy (lvh) is common, and if severe, may mimic hypertrophic obstructive cardiomyopathy. |
2005-09-01 |
2023-08-12 |
Not clear |
| J S Shah, P M Elliot. Fabry disease and the heart: an overview of the natural history and the effect of enzyme replacement therapy. Acta paediatrica (Oslo, Norway : 1992). Supplement. vol 94. issue 447. 2005-08-25. PMID:15895705. |
up to 60% of males with classic fabry disease have cardiac abnormalities, including left ventricular hypertrophy, valvular dysfunction and conduction abnormalities. |
2005-08-25 |
2023-08-12 |
Not clear |
| Cristina Chimenti, Maurizio Pieroni, Emanuela Morgante, Daniela Antuzzi, Andrea Russo, Matteo Antonio Russo, Attilio Maseri, Andrea Frustac. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation. vol 110. issue 9. 2005-03-25. PMID:15313943. |
prevalence of fabry disease in female patients with late-onset hypertrophic cardiomyopathy. |
2005-03-25 |
2023-08-12 |
Not clear |
| Cristina Chimenti, Maurizio Pieroni, Emanuela Morgante, Daniela Antuzzi, Andrea Russo, Matteo Antonio Russo, Attilio Maseri, Andrea Frustac. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation. vol 110. issue 9. 2005-03-25. PMID:15313943. |
fabry disease (fd) has been recognized as the cause of left ventricular hypertrophy in 6% of men with late-onset hypertrophic cardiomyopathy (hcm). |
2005-03-25 |
2023-08-12 |
Not clear |
| Maurizio Pieroni, Cristina Chimenti, Andrea Russo, Matteo Antonio Russo, Attilio Maseri, Andrea Frustac. Tissue Doppler imaging in Fabry disease. Current opinion in cardiology. vol 19. issue 5. 2005-01-28. PMID:15316452. |
the development of effective enzyme replacement/enhancement therapy makes of clinical relevance considering fabry disease in the differential diagnosis of patients with hypertrophic cardiomyopathy. |
2005-01-28 |
2023-08-12 |
Not clear |
| Masakazu Teragaki, Akemi Tanaka, Kaname Akioka, Hoang Thi Ngkoc Lan, Yasuaki Nishi, Tsunekazu Yamano, Junichi Yoshikaw. Fabry disease female proband with clinical manifestations similar to hypertrophic cardiomyopathy. Japanese heart journal. vol 45. issue 4. 2004-10-28. PMID:15353880. |
fabry disease female proband with clinical manifestations similar to hypertrophic cardiomyopathy. |
2004-10-28 |
2023-08-12 |
Not clear |
| K Komamura, M Higashi, N Yamad. Improvement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant alpha-galactosidase A. Heart (British Cardiac Society). vol 90. issue 6. 2004-06-15. PMID:15145857. |
improvement of cardiac hypertrophy and ventricular function in a man with fabry disease by treatment with recombinant alpha-galactosidase a. |
2004-06-15 |
2023-08-12 |
Not clear |
| Dominique-Paul Germai. [Fabry disease in 2004]. La Revue du praticien. vol 53. issue 20. 2004-05-20. PMID:15018073. |
some phenotypic variants of fabry disease are probably under-diagnosed among patients with so-called idiopathic hypertrophic cardiomyopathy on haemodialysis. |
2004-05-20 |
2023-08-12 |
Not clear |
| Hiroyuki Teraguchi, Toshihiro Takenaka, Aichi Yoshida, Syuhei Taguchi, Kenjiro Ninomiya, Hiroki Yoshida, Michiko Horinouchi, Suguru Yonezawa, Shoichiro Nakao, Shinichi Minagoe, Shuwa Te. [End-stage cardiac manifestations and autopsy findings in patients with cardiac fabry disease]. Journal of cardiology. vol 43. issue 2. 2004-04-20. PMID:15046052. |
we have previously reported a 3% prevalence of this cardiac variant in men with left ventricular hypertrophy, which we designated cardiac fabry disease. |
2004-04-20 |
2023-08-12 |
Not clear |
| D E L Wilcke. Overview of inherited metabolic disorders causing cardiovascular disease. Journal of inherited metabolic disease. vol 26. issue 2-3. 2004-03-05. PMID:12889664. |
hypertrophic cardiomyopathy may be confused with fabry disease, for which effective treatment is now available. |
2004-03-05 |
2023-08-12 |
Not clear |
| C-C Yang, L-W Lai, O Whitehair, W-L Hwu, S-C Chiang, Y-H H Lie. Two novel mutations in the alpha-galactosidase A gene in Chinese patients with Fabry disease. Clinical genetics. vol 63. issue 3. 2003-11-12. PMID:12694230. |
the genotype y222x is associated with classic fabry disease, with unexpectedly rapid deterioration of visual acuity, while t410a is associated with a milder fabry disease, with ventricular hypertrophy and neuropathic pain. |
2003-11-12 |
2023-08-12 |
Not clear |
| S R Ommen, R A Nishimura, W D Edward. Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy? Heart (British Cardiac Society). vol 89. issue 8. 2003-09-02. PMID:12860876. |
fabry disease: a mimic for obstructive hypertrophic cardiomyopathy? |
2003-09-02 |
2023-08-12 |
Not clear |
| C Kampmann, C M Wiethoff, C Martin, A Wenzel, R Kampmann, C Whybra, E Miebach, M Bec. Electrocardiographic signs of hypertrophy in fabry disease-associated hypertrophic cardiomyopathy. Acta paediatrica (Oslo, Norway : 1992). Supplement. vol 91. issue 439. 2003-05-23. PMID:12572838. |
we aimed to evaluate the utility of different electrocardiographic (ecg) parameters for assessing the degree and severity of hypertrophic cardiomyopathy in patients with fabry disease. |
2003-05-23 |
2023-08-12 |
Not clear |
| B Sachdev, P M Elliot. Isolated cardiac manifestations in Fabry disease: the UK experience. Acta paediatrica (Oslo, Norway : 1992). Supplement. vol 91. issue 439. 2003-05-23. PMID:12572839. |
at st george's hospital medical school, a national referral centre for hypertrophic cardiomyopathy in the uk, a study of 153 consecutively referred male patients revealed that 4% had fabry disease. |
2003-05-23 |
2023-08-12 |
Not clear |
| B Sachdev, P M Elliot. Isolated cardiac manifestations in Fabry disease: the UK experience. Acta paediatrica (Oslo, Norway : 1992). Supplement. vol 91. issue 439. 2003-05-23. PMID:12572839. |
all these patients had electrocardiographic (ecg) abnormalities, most of which were consistent with those found in patients with classic fabry disease: left ventricular hypertrophy, repolarization abnormalities and a prolonged qrs complex. |
2003-05-23 |
2023-08-12 |
Not clear |
| G Beer, P Reinecke, H E Gabbert, W Hort, H Kuh. Fabry disease in patients with hypertrophic cardiomyopathy (HCM). Zeitschrift fur Kardiologie. vol 91. issue 12. 2003-04-14. PMID:12490989. |
fabry disease in patients with hypertrophic cardiomyopathy (hcm). |
2003-04-14 |
2023-08-12 |
Not clear |
| G Beer, P Reinecke, H E Gabbert, W Hort, H Kuh. Fabry disease in patients with hypertrophic cardiomyopathy (HCM). Zeitschrift fur Kardiologie. vol 91. issue 12. 2003-04-14. PMID:12490989. |
unlike patients with the classical systemic fabry disease entity, who present with multiple organ involvement, patients with a cardiac variant of fabry disease are characterized mainly by myocardial hypertrophy. |
2003-04-14 |
2023-08-12 |
Not clear |
| G Beer, P Reinecke, H E Gabbert, W Hort, H Kuh. Fabry disease in patients with hypertrophic cardiomyopathy (HCM). Zeitschrift fur Kardiologie. vol 91. issue 12. 2003-04-14. PMID:12490989. |
therefore, the cardiac variant of fabry disease may be defined as a cardiomyocytic storage disorder, thus, mimicking the clinical features of hypertrophic obstructive and especially non-obstructive cardiomyopathy. |
2003-04-14 |
2023-08-12 |
Not clear |
| G Beer, P Reinecke, H E Gabbert, W Hort, H Kuh. Fabry disease in patients with hypertrophic cardiomyopathy (HCM). Zeitschrift fur Kardiologie. vol 91. issue 12. 2003-04-14. PMID:12490989. |
in patients with unexplained left ventricular hypertrophy the diagnosis of a cardiac variant of fabry disease is performed by light- and electron microscopic evaluation of endomyocardial catheter biopsy specimens and/or serologic investigations (decreased activity of alpha-galactosidase a in plasma or leucocytes). |
2003-04-14 |
2023-08-12 |
Not clear |
| G Beer, P Reinecke, H E Gabbert, W Hort, H Kuh. Fabry disease in patients with hypertrophic cardiomyopathy (HCM). Zeitschrift fur Kardiologie. vol 91. issue 12. 2003-04-14. PMID:12490989. |
several studies show that between 4% and 8% of unselected patients with the clinical features of hypertrophic non-obstructive cardiomyopathy have a cardiac variant of fabry disease. |
2003-04-14 |
2023-08-12 |
Not clear |